Qizheng Tibetan Medicine announced that the company and its subsidiaries plan to use up to RMB 1.8 billion of idle capital to entrust financial management to improve the efficiency of the use of funds and the level of profit. The investment period is valid for 12 months from the date of review and approval by the board of directors. The funding source is the company's own funds and subsidiaries.
奇正藏药：使用不超过18亿闲置资金进行委托理财
Qizheng Tibetan Medicine: Using no more than 1.8 billion idle funds to entrust financial management
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.